Soluble toll-like receptor 2 in HIV infection: association with disease progression.
Heggelund
Lars
L
Section of Clinical Immunology and Infectious Diseases, Medical Department, Rikshospitalet University Hospital, University of Oslo, Oslo, Norway.
Flo
Trude
T
Berg
Kristin
K
Lien
Egil
E
Mollnes
Tom Eirik
TE
Ueland
Thor
T
Aukrust
Pål
P
Espevik
Terje
T
Frøland
Stig S
SS
D000163:Acquired Immunodeficiency Syndrome / Q000097:blood; D023241:Antiretroviral Therapy, Highly Active; D015415:Biomarkers / Q000097:blood; D016516:CD4-CD8 Ratio; D003430:Cross-Sectional Studies; D018450:Disease Progression; D015658:HIV Infections / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D008137:Longitudinal Studies; D008562:Membrane Glycoproteins / Q000097:blood*; D011956:Receptors, Cell Surface / Q000097:blood*; D051195:Toll-Like Receptor 2; D051193:Toll-Like Receptors
D015415:Biomarkers; D008562:Membrane Glycoproteins; D011956:Receptors, Cell Surface; C495342:TLR2 protein, human; D051195:Toll-Like Receptor 2; D051193:Toll-Like Receptors